Cancer Screening in Older Adults.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27542429.
- Also identified by DOI 10.1016/j.mcna.2016.04.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.
Medical subject headings
- Breast Neoplasms
- Colorectal Neoplasms
- Early Detection of Cancer
- Life Expectancy
- Lung Neoplasms
- Prostatic Neoplasms